Investors & Media
Press Releases
2019
-
- September 13, 2019
-
Anokion Presents New Data Describing Transformative Therapeutic Approach for Treatment of Multiple Sclerosis at ECTRIMS Congress
Read More
-
- September 11, 2019
-
Anokion Acquires Kanyos Bio and Raises $40 Million to Advance First Product Candidate into Clinic in 2019
Read More
-
- January 16, 2019
-
Anokion Expands Leadership Team with Appointment of Simon Cooper, MBBS, as Chief Medical Officer
Read More